IkappaBalpha regulates Hes1 in osteoclast differentiation and resorption

Frontiers in Bioscience - Elite

Volumn 2 E, Issue 3, 2010, Pages 1065-1072

  Duan, Li ^a,b   De Vos, Paul ^a   Faas, Marijke ^a   Fan, Mingwen ^c   Ren, Yijin ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b HAINAN MEDICAL UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

Hes1; IkappaBalpha; NF kappaB; Notch; Osteoclast

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HES1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PRIMER DNA;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; GEL MOBILITY SHIFT ASSAY; HUMAN; MOUSE; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOLYSIS; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HOMEODOMAIN PROTEINS; HUMANS; I-KAPPA B PROTEINS; MICE; OSTEOCLASTS; POLYMERASE CHAIN REACTION;

EID: 77957359131     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. G. D. Roodman: Cell biology of the osteoclast. Exp. Hematol., 27, 1229-1241 (1999) (Pubitemid 29347472)
2. S. Khosla: The OPG/RANKL/RANK system. Endocrinology, 142, 5050-5055 (2001)
3. D. L. Lacey, E. Timms, H. L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y. X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney & W. J. Boyle: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 93, 165-176 (1998) (Pubitemid 28180851)
4. H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi & T. Suda: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA., 95, 3597-602 (1998)
5. G. Franzoso, L. Carlson, L. Xing, L. Poljak, E. W. Shores, K. D. Brown, A. Leonardi, T. Tran, B. F. Boyce & U. Siebenlist: Requirement for NF-êB in osteoclast and B-cell development. Genes Dev., 11, 3482-3496 (1997) (Pubitemid 28023969)
6. M. S. Hayden & S. Ghosh: Signaling to NF-kB. Genes Dev., 18, 2195-2224 (2004)
7. G. Bonizzi & M. Karin: The two NF-kB activation pathways and their role in innate and adaptive immunity. Trends Immunol., 25, 280-288 (2004) (Pubitemid 38610351)
8. S. Ghosh & M. Karin: Missing pieces in the NFkB puzzle. Cell, 109(Suppl.), 81-96 (2002)
9. C. Johnson, D. Van Antwerp & T. J. Hope: An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha. EMBO. J., 18, 6682-6693 (1999)
10. T. T. Huang, N. Kudo, M. Yoshida & S. Miyamoto: A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. Proc. Natl. Acad. Sci. USA., 97, 1014-1019 (2000) (Pubitemid 30080804)
11. C. Aguilera, R. Hoya-Arias, G. Haegeman, L. Espinosa & A. Bigas: Recruitment of IkappaBalpha to the Hes1 promoter is associated with transcriptional repression. Proc. Natl. Acad. Sci. U S A., 101, 16537-16542 (2004) (Pubitemid 39557748)
12. T. Iso, L. Kedes & Y. Hamamori: HES and HERP families: multiple effectors of the Notch signalling pathway. J. Cell. Physiol., 194, 237-255 (2003) (Pubitemid 36176887)
13. N. Chadwick, M. C. Nostro, M. Baron, R. Mottram, G. Brady & A. M. Buckle: Notch signaling induces apoptosis in primary human CD34+ hematopoietic progenitor cells. Stem Cells, 25, 203-210 (2007) (Pubitemid 46052992)
14. J. S. Mumm & R. Kopan: Notch signaling: from the outside in. Dev. Biol., 228, 151-165 (2000) (Pubitemid 32011983)
15. B. Sung, A. Murakami, B. O. Oyajobi & B. B. Aggarwal: Zerumbone abolishes RANKL-induced NF-{kappa}B activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss in athymic nude mice. Cancer Res., 69, 1477-1484 (2009)
16. N. Tanabe, M. Maeno, N. Suzuki, K. Fujisaki, H. Tanaka, B. Ogiso & K. Ito: IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts. Life Sci., 77, 615-626 (2005) (Pubitemid 40726349)
17. M. Tanaka, A. Sakai, S. Uchida, S. Tanaka, Nagashima, M. Katayama T., K. Yamaguchi & T. Nakamura: Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819. CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. Bone, 34, 940-948 (2004) (Pubitemid 38749231)
18. T. Kukita, N. Wada, A. Kukita, T. Kakimoto, F. Sandra, K. Toh, K. Nagata, T. Iijima, M. Horiuchi, H. Matsusaki, K. Hieshima, O. Yoshie & H. Nomiyama: RANKL-induced DC-STAMP is essential for osteoclastogenesis. J. Exp. Med., 200, 941-946 (2004) (Pubitemid 39362930)
19. M. Yagi, K. Ninomiya, N. Fujita, T. Suzuki, R. Iwasaki, K. Morita, N. Hosogane, K. Matsuo, Y. Toyama, T. Suda & T. Miyamoto: Induction of DC-STAMP by alternative activation and downstream signaling mechanisms. J. Bone Miner. Res., 22, 992-1001 (2007) (Pubitemid 351339721)
20. K. Sundaram, R. Nishimura, J. Senn, R. F. Youssef, S. D. London & S. V. Reddy: RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp. Cell Res., 313, 168-178 (2007) (Pubitemid 44958461)
21. H. T. Tan-Pertel, L. Walker, D. Browning, A. Miyamoto, G. Weinmaster & J. C. Gasson: Notch signaling enhances survival and alters differentiation of 32D myeloblasts. J. Immunol., 165, 4428-4436 (2000)
22. F. Moore, S. Buonocore, E. Aksoy, N. Ouled-Haddou, S. Goriely, E. Lazarova, F. Paulart, C. Heirman, E. Vaeremans, K. Thielemans, M. Goldman & V. Flamand: An alternative pathway of NF-kappaB activation results in maturation and T cell priming activity of dendritic cells overexpressing a mutated IkappaBalpha. J. Immunol., 178, 1301-1311 (2007) (Pubitemid 46154600)
23. H. Wang, E. Hertlein, N. Bakkar, H. Sun, S. Acharyya, J. Wang, M. Carathers, R. Davuluri & D. C. Guttridge: NFkappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes. Mol. Cell Biol., 27, 4374-4387 (2007) (Pubitemid 46906562)
24. S. Bai, R. Kopan, W. Zou, M. J. Hilton, C. T. Ong, F. Long, F. P. Ross & S. L. Teitelbaum: NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. J. Biol. Chem., 283, 6509-6518 (2008)
25. S. T. Moran, A. Cariappa, H. Liu, B. Muir, D. Sgroi, C. Boboila & S. Pillai: Synergism between NF-kappa B1/p50 and Notch2 during the development of marginal zone B lymphocytes. J. Immunol., 179, 195-200 (2007) (Pubitemid 46986534)
26. J. Bash, W. X. Zong, S. Banga, A. Rivera, D. W. Ballard, Y. Ron & C. Gélinas: Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors. EMBO. J., 18, 2803-2811 (1999) (Pubitemid 29233952)
27. L. Espinosa, J. Inglés-Esteve, A. Robert-Moreno & A. Bigas: IkappaBalpha and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFkappaB pathways. Mol. Biol. Cell, 14, 491-502 (2003) (Pubitemid 36237011)